In this review, we reexamine

noteworthy examples where pharmacogenetic testing information was added to drug labelling to explore how the available evidence, potential public health impact, and predictive utility of each pharmacogenetic biomarker impacts clinical uptake.

Modern Equipment

Click for more information Clinical and Regulatory Considerations for Pharmacogenetic Testing

Leave a Reply

Your email address will not be published.

You may use these <abbr title="HyperText Markup Language">HTML</abbr> tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

*

Hi, How Can We Help You?